Minimally invasive colorectal cancer surgery: an observational study of medicare advantage and fee-for-service beneficiaries
Surgical Endoscopy · 2024
DOI: 10.1007/s00464-024-11168-0 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Emna Bakillah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Perelman School of Medicine of the University of Pennsylvania, 3400 Spruce St, 4 Maloney, Philadelphia, PA, 19104, USA. Emna.B…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Fee-for-Service Plans, Medicare Part C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, National Institute on Minority Health and Health Disparities.
Abstract (Originalsprache)
Background
Enrollment of Medicare beneficiaries in medicare advantage (MA) plans has been steadily increasing. Prior research has shown differences in healthcare access and outcomes based on Medicare enrollment status. This study sought to compare utilization of minimally invasive colorectal cancer (CRC) surgery and postoperative outcomes between MA and Fee-for-Service (FFS) beneficiaries.
Methods
A retrospective cohort study of beneficiaries ≥ 65.5 years of age enrolled in FFS and MA plans was performed of patients undergoing a CRC resection from 2016 to 2019. The primary outcome was operative approach, defined as minimally invasive (laparoscopic) or open. Secondary outcomes included robotic assistance, hospital length-of-stay, mortality, discharge disposition, and hospital readmission. Using balancing weights, we performed a tapered analysis to examine outcomes with adjustment for potential confounders.
Results
MA beneficiaries were less likely to have lymph node (12.9 vs 14.4%, p < 0.001) or distant metastases (15.5% vs 17.0%, p < 0.001), and less likely to receive chemotherapy (6.2% vs 6.7%, p < 0.001), compared to FFS beneficiaries. MA beneficiaries had a higher risk-adjusted likelihood of undergoing laparoscopic CRC resection (OR 1.12 (1.10–1.15), p < 0.001), and similar rates of robotic assistance (OR 1.00 (0.97–1.03), p = 0.912), compared to FFS beneficiaries. There were no differences in risk-adjusted length-of-stay ( β coefficient 0.03 (− 0.05–0.10), p = 0.461) or mortality at 30-60-and 90-days (OR 0.99 (0.95–1.04), p = 0.787; OR 1.00 (0.96–1.04), p = 0.815; OR 0.98 (0.95–1.02), p = 0.380). MA beneficiaries had a lower likelihood of non-routine disposition (OR 0.77 (0.75–0.78), p < 0.001) and readmission at 30-60-and 90-days (OR 0.76 (0.73–0.80), p < 0.001; OR 0.78 (0.75–0.81), p < 0.001; OR 0.79 (0.76–0.81), p < 0.001).
Conclusions
MA beneficiaries had less advanced disease at the time of CRC resection and a greater likelihood of undergoing a laparoscopic procedure. MA enrollment is associated with improved health outcomes for elderly beneficiaries undergoing operative treatment for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Perelman School of Medicine of the University of Pennsylvania, 3400 Spruce St, 4 Maloney, Philadelphia, PA, 19104, USA. Emna.Bakillah@pennmedicine.upenn.edu.
- Department of Surgery, Center for Surgery and Health Economics, Philadelphia, PA, USA. Emna.Bakillah@pennmedicine.upenn.edu.
- Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. Emna.Bakillah@pennmedicine.upenn.edu.
- Department of Surgery, Perelman School of Medicine of the University of Pennsylvania, 3400 Spruce St, 4 Maloney, Philadelphia, PA, 19104, USA.
- Department of Surgery, Center for Surgery and Health Economics, Philadelphia, PA, USA.
- Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Emna Bakillah
Förderung
- NIMHD NIH HHS
- National Institute on Minority Health and Health Disparities
Zitieren
APA
Bakillah, E., Sharpe, J., Wirtalla, C., Goldberg, D., Altieri, M. S., Aarons, C. B., Keele, L. J., & Kelz, R. R. (2024). Minimally invasive colorectal cancer surgery: an observational study of medicare advantage and fee-for-service beneficiaries. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-11168-0
Vancouver
Bakillah E, Sharpe J, Wirtalla C, Goldberg D, Altieri MS, Aarons CB, et al. Minimally invasive colorectal cancer surgery: an observational study of medicare advantage and fee-for-service beneficiaries. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-11168-0
BibTeX
@article{Bakillah2024,
author = {Bakillah, Emna and Sharpe, James and Wirtalla, Chris and Goldberg, Drew and Altieri, Maria S and Aarons, Cary B and Keele, Luke J and Kelz, Rachel R},
title = {Minimally invasive colorectal cancer surgery: an observational study of medicare advantage and fee-for-service beneficiaries},
journal = {Surgical Endoscopy},
year = {2024},
doi = {10.1007/s00464-024-11168-0}
}
EUVIMED